NCT00075335View on ClinicalTrials.gov

AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy
Interventions
DRUG

AMD3100 (Mozobil plerixafor)

AMD 3100 (Mozobil plerixafor)mobilized peripheral blood hematopoietic progenitor cells from healthy volunteers will be characterized by cellular content and immunological properties.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00075335 - AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation | Biotech Hunter | Biotech Hunter